Inlay

//

ProfilePosts

Loading...

Don’t miss the first webinar in our Deep Dive Series, happening June 30th! Explore the mechanisms and clinical development of PD-1/VEGF bispecifics with expert faculty examining emerging biology, engineering strategies, and the latest clinical data. sitcancer.org/edu/webinars/targets-for-cancer-io

New #JITC article: "Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer" jitc.bmj.com/content/14/6... #JournalforImmunoTherapyofCancer #cancer #research🧪

#CIM – On SITC's Forward Fund Friday, we recognize the opportunities provided via your donations. Providing Early Career Scientists, the funding to share their research through travel awards is catapulting careers in #IO. Contribute and make an impact today. givebutter.com/sitc-forward... #GiveBack

Opportunities and challenges with myeloid cells in cancer biology! Access in-depth reviews and questions with a new #JITC special series, "Myeloid Cells in Immuno-Oncology", edited by Drs. Dmitry I. Gabrilovich, Jennifer L. Guerriero, and Judith A. Varner. View full series: https://ow.ly/VWMz50ZbbuI

Expert SITC speaker Lili Yang, PhD, UCLA is sharing insights on serotonin transporter inhibition at JACI 2026. Explore the latest updates on intratumoral therapies July 22–24, in Kagawa, Japan or virtual. Learn more: https://ow.ly/Ml0i50Z2ek4 OncoDaily

Join us for the Targets for Cancer IO: A Deep Dive Series—an expert-led webinar program exploring cutting-edge science and therapeutic innovation in immuno-oncology. Learn more about these webinars and register here: https://www.sitcancer.org/edu/webinars/targets-for-cancer-io

New #JITC commentary: "Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions" jitc.bmj.com/content/14/6... #JournalforImmunoTherapyofCancer #research 🧪

1h

4d

3d

4d

1d

5d

Empowering the next-generation of investigators and advancing the field of cancer immunotherapy

givebutter.com

SITC Forward Fund Donations

New #JITC review: "Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy" jitc.bmj.com/content/14/6... #cancer #IO 🧪

Society for Immunotherapy of Cancer

4h

Please take the survey and re-post to help grow response! Thanks. @oncodaily.bsky.social

5h

Society for Immunotherapy of Cancer

#CIM – It’s Forward Fund (FF) Friday. Your donation to the FF provides ECS opportunities to share their research w/ IO leaders through SITC travel awards & Early Career Investigator Awards. Your support is launching careers in IO to benefit Cx patients. givebutter.com/sitc-forward...

4d

Society for Immunotherapy of Cancer

Please re-post to reach as many #cancer #immunotherapy #patients as possible!

5d

Deb Collyar